# Triple Therapy With Tegoprazan in H. Pylori Positive Patients

> **NCT03498456** · PHASE3 · COMPLETED · sponsor: **HK inno.N Corporation** · enrollment: 284 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Tegoprazan/Amoxicillin/Clarithromycin
- **DRUG:** Lansoprazole/Amoxicillin/Clarithromycin

## Key facts

- **NCT ID:** NCT03498456
- **Lead sponsor:** HK inno.N Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-28
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 284 (ACTUAL)
- **Last updated:** 2020-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03498456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03498456, "Triple Therapy With Tegoprazan in H. Pylori Positive Patients". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03498456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*